Antimicrobial Resistance (AMR) Genotyping Panels Market Outlook Signals Expansion To $2.8 Billion Through 2030

The antimicrobial resistance (AMR) genotyping panels market is on track for significant expansion in the coming years, driven by advancements in diagnostics and growing awareness around resistance surveillance. This sector is set to experience rapid growth as new technologies and regulatory emphasis continue to shape its trajectory.

Antimicrobial Resistance Genotyping Panels Market Size and Growth Outlook
Forecasts project the AMR genotyping panels market will reach a value of $2.81 billion by 2030, expanding at a compound annual growth rate (CAGR) of 14.1%. This robust growth is fueled by increasing investments in infectious disease diagnostics, a rising preference for rapid point-of-care testing, and the broadening reach of genomic epidemiology initiatives. Additionally, the integration of AMR data analytics and heightened regulatory scrutiny around resistance monitoring further contribute to market expansion. Key trends expected to influence this market include greater adoption of multiplex resistance detection panels, wider use of rapid molecular diagnostic tools, enhanced incorporation of genomic surveillance systems, growth in hospital-based AMR testing, and a stronger focus on early identification of resistance patterns.

The antimicrobial resistance (amr) genotyping panels market size has grown rapidly in recent years. It will grow from $1.45 billion in 2025 to $1.66 billion in 2026 at a compound annual growth rate (CAGR) of 14.4%. The growth in the historic period can be attributed to rising prevalence of antimicrobial resistance, increased hospital-acquired infections, expansion of molecular diagnostic capabilities, growing awareness of resistance monitoring, availability of advanced genotyping technologies.

Download a free sample of the antimicrobial resistance (amr) genotyping panels market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30196&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Leading Companies Driving the AMR Genotyping Panels Market
The industry features several prominent players, including Thermo Fisher Scientific Inc., F Hoffmann La Roche Ltd., Abbott Laboratories, Illumina Inc., bioMérieux SA., Bruker Corporation, QIAGEN NV., Cepheid Inc., Integrated DNA Technologies Inc., Seegene Inc., Oxford Nanopore Technologies plc., Streck Inc., MedGenome Inc., Vela Diagnostics Pte. Ltd., Agena Bioscience Inc., CD Genomics Inc., Curetis GmbH, T2 Biosystems Inc., 3B BlackBio Biotech India Ltd., Genefirst Ltd., and OpGen Inc. A notable development occurred in June 2025 when bioMérieux acquired Day Zero Diagnostics for $25 million, aiming to enhance its next-generation sequencing (NGS) and rapid antimicrobial resistance diagnostic capabilities. Day Zero Diagnostics, a US-based firm, specializes in rapid whole-blood sample preparation, genome sequencing, and machine learning analytics for pathogen detection and antibiotic resistance profiling, positioning bioMérieux to better tackle infectious disease challenges.

Emerging Trends Transforming the AMR Genotyping Panels Industry
Companies within the AMR genotyping panels market are emphasizing the development of innovative multiplex PCR-based research assays that enable the simultaneous detection of multiple pathogens and antibiotic resistance genes in a single test. These assays improve research efficiency and accelerate the identification of emerging resistance patterns. Multiplex PCR technology amplifies and detects numerous genetic targets in one reaction, streamlining diagnostics and research processes.

View the full antimicrobial resistance (amr) genotyping panels market report:
https://www.thebusinessresearchcompany.com/report/global-antimicrobial-resistance-amr-genotyping-panels-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

For example, in September 2025, Molecular Designs, a US-based molecular diagnostics and research assay firm, introduced the Urogenital Microbiota with ABX 53 Simplicity Panel. This multiplex PCR-based assay detects 28 urogenital and urinary microbial targets-including bacterial, fungal, and protozoan pathogens-alongside 25 antibiotic resistance gene markers all in one test. The panel offers same-day results and is available in both 96-well and 384-well plate formats, featuring breakaway panels in the 96-well version to minimize reagent waste.

Detailed Segmentation of the AMR Genotyping Panels Market
This report categorizes the AMR genotyping panels market into several key segments for a comprehensive understanding:

1) By Product Type: Custom Panels and Pre-Designed Panels
2) By Technology: Polymerase Chain Reaction (PCR)-Based, Microarray-Based, Next-Generation Sequencing (NGS)-Based, and Other Technologies
3) By Application: Clinical Diagnostics, Research, Drug Development, and Other Applications
4) By End-User: Hospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, and Other End-Users

Further subcategories include:
- Custom Panels such as Pathogen-Specific Panels, Resistance Gene-Focused Panels, Multiplex Detection Panels, Targeted Mutation Panels, and Research Application Panels
- Pre-Designed Panels comprising Standardized Diagnostic Panels, Broad-Spectrum Resistance Panels, Disease-Specific Panels, Commercially Validated Panels, and Ready-to-Use Screening Panels

Together, these segments offer detailed insights into the diverse products, technologies, and user bases that are shaping the future landscape of the AMR genotyping panels market.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.